Dr. Greenbaum is a clinical investigator who focuses on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune-mediated beta cell function. She has conducted studies evaluating beta cell function and other physiologic and immune changes that occur during the progression of the natural history of type 1 diabetes.